The FINANCIAL -- Pfizer Inc. announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech companies as part of the Pfizer Breakthrough Growth Initiative (PBGI). Through PBGI, Pfizer is investing up to $500 million in biotechnology companies, providing funding and access to Pfizer’s scientific expertise to help ensure the continuity of promising clinical development programs of potential future strategic interest to Pfizer.…
Read More »
The FINANCIAL -- Pfizer Inc. announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech companies as part of the Pfizer Breakthrough Growth Initiative (PBGI). Through PBGI, Pfizer is investing up to $500 million in biotechnology companies, providing funding and access to Pfizer’s scientific expertise to…
You might be interested in
The FINANCIAL — Over the weekend of the 6th through 7th of August 2022, US senators voted through the night…
The FINANCIAL — Globally-significant events have driven recent financial market volatility and contributed to the emergence of a risk-off environment, according…
Commodity and risk currencies rallied overnight on reports the US may soon rollback tariffs on Chinese consumer goods. Asian stock…
The FINANCIAL — Even with the tremendous volatility in the sector, there are many more traditional hedge funds investing in…